Results that speak for themselves.
Regular Content
Features periodically posted articles & updates that are available to everyone. All recommendations posted in this section are intended to help non-members. I strongly encourage you to check this section often.
When you realize a gain from my recommendations, then support my efforts at Rx Investors by subscribing to the site.
Premium Content
Features regularly posted articles, alerts & updates made available to RXI’s premium members. To access RXI's Premium Content, simply subscribe to the site.
Member Forum
Accessible by Premium PLUS members.
Open Positions
Open Positions are simply buy recommendations that remain open until a sell recommendation has been issued. Features include: (1) price targets, (2) time horizons (12 months), (3) opportunity rankings and (4) dated citations.
Since RXI was launched in mid-March 2010, I have made a total of 67 buy recommendations. Of those 67 recommendations, 45 sell recommendations have been issued. Sells recommendations are recorded inside the Closed Positions section (see below). Currently, there are 22 Open Positions.
Accessible by Premium PLUS members..
77.8% (35/45) Profitable Closed Positions
Closed Positions stem from sell recommendations. They contain the same information as Open Positions including citations to both buy and sell recommendations as well as dates and specific prices. Sell recommendations may result in either a gain or loss, which is based on the recommended buy and sell prices.
Worth noting, most of our premium members have realized some very nice gains during tough market conditions.
Catalyst Stocks
Catalyst Stocks is a list of drug, device and diagnostic makers with pending regulatory and/or clinical events, i.e. potential catalysts during 2010 and beyond. To simplify research, the list has been sorted by number of outstanding clinical and / or regulatory events.
My aim is to earn and retain your business for the long-term.